Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

PRESS DIGEST- Canada-March 3

Published 2017-03-03, 05:48 a/m
© Reuters.  PRESS DIGEST- Canada-March 3
CMED
-

March 3 (Reuters) - The following are the top stories from selected Canadian newspapers. Reuters has not verified these stories and does not vouch for their accuracy.

THE GLOBE AND MAIL

** British Columbia's 15 percent tax on foreign home buyers violates Canada's Charter of Rights and Freedoms and "perpetuates prejudice and stereotyping on the basis of national origin," says the plaintiff in a proposed class-action lawsuit. The lawsuit, which still must be certified, was first filed in September by Jing Li, a Chinese citizen who moved to Canada in 2013. https://tgam.ca/2mlmNJV

** The Alberta government is going on the offensive to defend newly approved pipelines, vowing to intervene to stop any legal action aimed at slowing down the expansion of the Trans Mountain pipeline. https://tgam.ca/2lB4Qmb

** Prime Minister Justin Trudeau is rejecting recommendations from British Columbia's top health officials to widen the scope of his government's decriminalization agenda beyond marijuana to help stem the country's growing opioid crisis. https://tgam.ca/2llouqU

NATIONAL POST

** The federal government needs to create a special force to patrol the vast frontier between Canada and the United States because the Royal Canadian Mounted Police is stretched too thin, says the head of the union representing the nation's border officers. Greenpeace, after repeated attacks against Montreal-based forest products company Resolute Forest Products RFP.N for "destroying" Canada's boreal forests, now says that it was merely stating an opinion about the logging activity, not a fact. Medical marijuana producer CanniMed Therapeutics CMED.TO said on Thursday it has signed a letter of intent with PharmaChoice, a member-owned cooperative, that gives CanniMed exclusive distribution privileges at PharmaChoice stores in exchange for CanniMed's provision of training.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.